| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. | SVP, Regulatory Affairs | Common Stock | 274,867 | $1,147,019 | $4.17 | 10 Mar 2026 | Direct |
| Aquestive Therapeutics, Inc. | SVP, Regulatory Affairs | Non-Qualified Stock Option (right to buy) | 75,000 | 09 Mar 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AQST | Aquestive Therapeutics, Inc. | 09 Mar 2026 | 3 | -$105,623 | 4 | SVP, Regulatory Affairs | 11 Mar 2026, 12:52 |
| AQST | Aquestive Therapeutics, Inc. | 02 Dec 2025 | 1 | -$12,352 | 4 | SVP, Regulatory Affairs | 04 Dec 2025, 10:39 |
| AQST | Aquestive Therapeutics, Inc. | 15 May 2025 | 1 | $0 | 4 | SVP, Regulatory Affairs | 15 May 2025, 12:59 |
| AQST | Aquestive Therapeutics, Inc. | 25 Apr 2025 | 0 | $0 | 3 | SVP Regulatory Affairs | 07 May 2025, 09:10 |